Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Prophylaxis of Esophageal Varices in Patients Treated With Atezolizumab and Bevacizumab for Advanced Hepatocellular Carcinoma.

NCT06961526 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06961526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06961526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Prophylaxis of Esophageal Varices in Patients Treated With Atezolizumab and Bevacizumab for Advanced Hepatocellular Carcinoma.
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Recruiting
Start date
February 15, 2025
Completion date
July 31, 2026
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal and/or gastric varices, hepatocellular carcinoma (hcc)